ABBV — Abbvie Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Abbvie, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	45,804	56,197	58,054	54,318	56,334
Cost of Revenue
Gross Profit	30,547	38,883	41,527	36,092	39,430
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	34,441	38,273	39,937	41,561	47,197
Operating Profit	11,363	17,924	18,117	12,757	9,137
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,398	12,989	13,477	6,250	3,716
Provision for Income Taxes
Net Income After Taxes	4,622	11,549	11,845	4,873	4,286
Minority Interest
Net Income Before Extraordinary Items
Net Income	4,616	11,542	11,836	4,863	4,278
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,556	11,468	11,782	4,820	4,238
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.9	7.32	7.78	4.54	5.97
Dividends per Share